← The Wire
RYTMNasdaq
RHYTHM PHARMACEUTICALS, INC.
Pharmaceutical Preparations · DE · CIK 1649904
Transforms lives with precision medicines for rare neuroendocrine diseases, focusing on MC4R agonists
red 8-K · 90d⚡ Elevated coverage
$6.06B
Market cap
$110.04
Last close
+0.2%
1D
+8.5%
5D
828K
Volume
Price · last 39 sessions+28.6%
May 4L $84.35 · H $110.04Jun 29
196
Total filings
Jun 25, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 25, 20268-KReg FD Disclosure · Company UpdateJun 15, 2026DEFA14ADEFA14AMay 29, 2026DEFA14ADEFA14AMay 5, 202610-Q10-QMay 5, 20268-KResults of OperationsMay 5, 2026DEF 14ADEF 14AApr 29, 20268-KExecutive Change · Reg FD DisclosureApr 3, 20268-KReg FD Disclosure · Company UpdateMar 26, 20268-KReg FD Disclosure · Company UpdateMar 20, 20268-KReg FD Disclosure · Company UpdateMar 16, 20268-KReg FD Disclosure · Company UpdateMar 2, 202610-K10-KFeb 26, 20268-KResults of OperationsFeb 26, 20268-KResults of Operations · Reg FD DisclosureJan 9, 20268-KExecutive ChangeDec 19, 20258-KReg FD Disclosure · Company UpdateDec 11, 20258-KReg FD Disclosure · Company UpdateNov 7, 202510-Q10-QNov 4, 20258-KResults of OperationsNov 4, 202510-Q10-QAug 5, 20258-KResults of OperationsAug 5, 20258-KCompany UpdateJul 11, 2025424B5424B5Jul 10, 2025424B5424B5Jul 9, 20258-KReg FD Disclosure · Company UpdateJul 9, 20258-KBylaw Amendment · Shareholder VoteJun 26, 202510-Q10-QMay 7, 20258-KResults of OperationsMay 7, 2025DEFA14ADEFA14AApr 29, 2025DEF 14ADEF 14AApr 29, 20258-KReg FD Disclosure · Company UpdateApr 7, 20258-KAgreement Terminated · Reg FD DisclosureMar 20, 20258-KCompany UpdateFeb 28, 202510-K10-KFeb 28, 20258-KResults of OperationsFeb 26, 20258-KResults of Operations · Reg FD DisclosureJan 10, 2025SC 13GSC 13GNov 14, 202410-Q10-QNov 6, 20248-KResults of OperationsNov 5, 20248-KShareholder VoteSep 19, 202410-Q/A10-Q/AAug 14, 2024DEFA14ADEFA14AAug 7, 202410-Q10-QAug 6, 20248-KResults of OperationsAug 6, 20248-KCompany UpdateJul 10, 2024DEFA14ADEFA14AJun 17, 20248-KCompany UpdateJun 17, 202410-Q10-QMay 7, 20248-KResults of OperationsMay 7, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 20248-KMaterial Agreement · Security-Holder RightsApr 16, 20248-KMaterial Agreement · Equity IssuanceApr 1, 2024SC 13DSC 13DMar 20, 20248-KMaterial AgreementFeb 29, 2024424B5424B5Feb 29, 202410-K10-KFeb 29, 20248-KResults of Operations · Company UpdateFeb 22, 2024SC 13GSCHEDULE 13GFeb 13, 2024SC 13GSC 13GFeb 12, 20248-KReg FD DisclosureJan 4, 20248-KMaterial Agreement · Equity IssuanceJan 4, 20248-KBylaw AmendmentDec 18, 20238-KCompany UpdateDec 6, 202310-Q10-QNov 8, 20238-KResults of OperationsNov 7, 20238-KCompany UpdateAug 21, 20238-KExecutive ChangeAug 8, 20238-KExecutive ChangeAug 3, 202310-Q10-QAug 1, 20238-KResults of OperationsAug 1, 20238-KShareholder VoteJun 22, 202310-Q10-QMay 2, 20238-KResults of OperationsMay 2, 2023DEFA14ADEFA14AApr 27, 2023DEF 14ADEF 14AApr 27, 20238-KCompany UpdateMar 10, 202310-K10-KMar 1, 20238-KResults of OperationsMar 1, 2023
Insider Activity
In the 90 days to Mar 4, 2026: 3 sold $3.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 | German Christopher PaulCorporate Controller & CAO | Sell | 5,614 | $89.56 | $503K |
| Feb 19, 2026 | Smith Hunter CChief Financial Officer | Sell | 1,692 | $100.92 | $171K |
| Feb 19, 2026 | Smith Hunter CChief Financial Officer | Sell | 1,308 | $100.27 | $131K |
| Feb 19, 2026 | Smith Hunter CChief Financial Officer | Sell | 800 | $102.10 | $82K |
| Feb 19, 2026 | Smith Hunter CChief Financial Officer | Sell | 585 | $103.28 | $60K |
| Feb 17, 2026 | Smith Hunter CChief Financial Officer | Sell | 1,200 | $99.42 | $119K |
| Feb 17, 2026 | Smith Hunter CChief Financial Officer | Sell | 1,069 | $103.00 | $110K |
| Feb 17, 2026 | Smith Hunter CChief Financial Officer | Sell | 900 | $101.70 | $92K |
| Feb 17, 2026 | Smith Hunter CChief Financial Officer | Sell | 200 | $103.84 | $21K |
| Feb 17, 2026 | Smith Hunter CChief Financial Officer | Sell | 200 | $100.52 | $20K |
| Feb 12, 2026 | Smith Hunter CChief Financial Officer | Sell | 800 | $98.99 | $79K |
| Feb 12, 2026 | Smith Hunter CChief Financial Officer | Sell | 400 | $97.67 | $39K |
| Feb 12, 2026 | Smith Hunter CChief Financial Officer | Sell | 292 | $96.26 | $28K |
| Feb 12, 2026 | Smith Hunter CChief Financial Officer | Sell | 100 | $100.10 | $10K |
| Feb 11, 2026 | Smith Hunter CChief Financial Officer | Sell | 2,266 | $98.37 | $223K |
| Feb 11, 2026 | Smith Hunter CChief Financial Officer | Sell | 400 | $99.44 | $40K |
| Feb 11, 2026 | Smith Hunter CChief Financial Officer | Sell | 100 | $100.85 | $10K |
| Feb 10, 2026 | Smith Hunter CChief Financial Officer | Sell | 1,913 | $102.66 | $196K |
| Feb 10, 2026 | Smith Hunter CChief Financial Officer | Sell | 700 | $103.68 | $73K |
| Feb 10, 2026 | Smith Hunter CChief Financial Officer | Sell | 100 | $104.76 | $10K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
⚡ Elevated coverageCoverage (30d): 1 reputable article.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance